Springfield, MO, United States of America

Thomas J Marren

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Archimica Gmbh. Active years: 2011.


% Patents Active = 100.0



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas J Marren: Innovator in Enantiomeric Resolution

Introduction

Thomas J Marren is a notable inventor based in Springfield, MO (US). He has made significant contributions to the field of chemistry, particularly in the area of enantiomeric resolution. His work has implications for the pharmaceutical industry, enhancing the efficacy of certain medications.

Latest Patents

Marren holds a patent for the "Process of enantiomeric resolution of D,L-(±)-threo-methylphenidate." This innovative process involves preparing the d-threo isomer of methylphenidate hydrochloride through a series of steps. These steps include resolving a racemic mixture with a tertiary amine base, basifying the resulting chiral acid salt, and converting it into the desired hydrochloride form. He has 1 patent to his name.

Career Highlights

Marren is currently employed at Archimica GmbH, where he continues to apply his expertise in chemical processes. His work at the company focuses on developing methods that enhance the production of pharmaceutical compounds.

Collaborations

Throughout his career, Marren has collaborated with several professionals in the field, including James E Aldred, Jr and Yu Ji. These collaborations have contributed to the advancement of his research and the successful implementation of his patented processes.

Conclusion

Thomas J Marren is a distinguished inventor whose work in enantiomeric resolution has made a significant impact in the pharmaceutical industry. His innovative processes and collaborations highlight his commitment to advancing chemical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…